Cornerstone Capital Management Holdings’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-33,617
Closed -$418K 1447
2016
Q4
$418K Buy
33,617
+200
+0.6% +$2.41K ﹤0.01% 1119
2016
Q3
$456K Sell
33,417
-2,100
-6% -$21.1K ﹤0.01% 1085
2016
Q2
$263K Buy
35,517
+31,200
+723% +$234K ﹤0.01% 1154
2016
Q1
$28K Sell
4,317
-47,600
-92% -$267K ﹤0.01% 1437
2015
Q4
$324K Buy
51,917
+44,017
+557% +$289K ﹤0.01% 1118
2015
Q3
$46K Hold
7,900
﹤0.01% 1413
2015
Q2
$65K Hold
7,900
﹤0.01% 1336
2015
Q1
$65K Buy
7,900
+4,400
+126% +$32.5K ﹤0.01% 1297
2014
Q4
$24K Buy
3,500
+2,200
+169% +$13.8K ﹤0.01% 1231
2014
Q3
$7K Buy
+1,300
New +$7.59K ﹤0.01% 1252

Other funds holding ARIA

Cornerstone Capital Management Holdings's ARIA Position: Q1 2017 in Review

Cornerstone Capital Management Holdings sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 33,617 shares — an estimated $418K sold.

Cornerstone Capital Management Holdings first reported a position in ARIA in Q3 2014 and held it in 10 quarters. The position peaked at $456K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Cornerstone Capital Management Holdings reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 33,617 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $418K.
  • Cornerstone Capital Management Holdings first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 10 quarters.
  • Cornerstone Capital Management Holdings's Ariad Pharmaceuticals Inc position peaked at $456K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2017, filed 10 May 2017.